David Milewski, PHD

National Cancer Institute – Postdoctoral Researcher

Dr. Milewski is a molecular biologist in the Genetics Branch at the National Cancer Institute. The goal of his research is to develop new targeted therapy combinations for high-risk pediatric solid tumors. Dr. Milewski specializes in adolescent and young adult sarcomas, particularly rhabdomyosarcoma and osteosarcoma, and studies their unique biological properties that can be exploited with combination therapies including immunotherapy.
Dr. Milewski earned his PhD in Molecular and Developmental Biology from a joint program between Cincinnati Children’s Hospital Medical Center and the College of Medicine at the University of Cincinnati.